自己免疫疾患、肺塞栓リスク高
                      
                      
                      文献:Zoller B et al.Risk of   pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up   study from Sweden.The Lancet, Early Online Publication, 26 November   2011.
                      
                       
                      静脈性血栓塞栓症による入院歴のない自己免疫疾患患者53万5538人を対象に、自己免疫疾患と肺塞栓症リスクの関連を全国追跡調査で検証。自己免疫疾患による入院1年目の肺塞栓症標準化罹患比は6.38だった。すべての自己免疫疾患と入院1年目の肺塞栓症リスクの有意な増加とは関連し、特に血小板減少性紫斑病などはリスクが高かった。
                      
                      Risk   of pulmonary embolism in patients with autoimmune disorders: a nationwide   follow-up study from Sweden
                      
                      Background
                      Some autoimmune   disorders have been linked to venous thromboembolism. We examined whether there   is an association between autoimmune disorders and risk of pulmonary   embolism.
                      
                      Methods
                      We followed up all individuals in Sweden without   previous hospital admission for venous thromboembolism and with a primary or   secondary diagnosis of an autoimmune disorder between Jan 1, 1964, and Dec 31,   2008, for hospital admission for pulmonary embolism. We obtained data from the   MigMed2 database, which has individual-level information about all registered   residents of Sweden. The reference population was the total population of   Sweden. We calculated standardised incidence ratios (SIRs) for pulmonary   embolism, adjusted for individual variables, including age and   sex.
                      
                      Findings
                      535 538 individuals were admitted to hospital because of an   autoimmune disorder. Overall risk of pulmonary embolism during the first year   after admission for an autoimmune disorder was 6・38 (95% CI 6・19?6・57). All the   33 autoimmune disorders were associated with a significantly increased risk of   pulmonary embolism during the first year after admission. However, some had a   particularly high risk?eg, immune thrombocytopenic purpura (10・79, 95% CI   7・98?14・28), polyarteritis nodosa (13・26, 9・33?18・29), polymyositis or   dermatomyositis (16・44, 11・57?22・69), and systemic lupus erythematosus (10・23,   8・31?12・45). Overall risk decreased over time, from 1・53 (1・48?1・57) at 1?5   years, to 1・15 (1・11?1・20) at 5?10 years, and 1・04 (1・00?1・07) at 10 years and   later. The risk was increased for both sexes and all age   groups.
                      
                      Interpretation
                      Autoimmune disorders are associated with a high   risk of pulmonary embolism in the first year after hospital admission. Our   findings suggest that these disorders in general should be regarded as   hypercoagulable disorders.
                      
                      Funding
                      Swedish Research Council, Swedish   Council for Working Life and Social Research, Swedish Research Council Formas,   Region Skane.